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Background: Monitoring activity of specific signaling pathways in vivo is challenging and requires highly sensitive
methods to detect dynamic perturbations in whole organisms.
Results: In vivo gene delivery of a luciferase reporter followed by bioluminiscence imaging allows measuring NF-κB
activity in mice liver and lungs.
Conclusions: This protocol allows a direct measure of NF-κB activity through quantification of bioluminescence
signal, demonstrating its accuracy and sensitivity in different animal models and experimental conditions. Variants
could be also applied for the analysis of NF-κB activity in different tissues or for studying other signaling pathways
in vivo.Background
Monitoring biological processes in vivo remains experimen-
tally challenging. Visualization of biochemical perturbations
in whole organisms requires highly sensitive methods that
allow detection in a quantitative and reproducible manner
[1-3]. Reporter gene approaches are based on the use of
specific regulatory sequences attached to genes that confer
organisms a property that could be easily detected and
quantified, typically light or fluorescence emission [4].
Different luciferase and fluorescent proteins-based
strategies have been developed for monitoring signaling
pathways involved in cancer and aging [5-11].
Most of the available strategies rely on the generation of
transgenic mice that stably express reporter genes. These
mutant animals allow dynamic studies of complex
processes, as the activity of the monitored signaling path-
ways could be recorded at different time points during
lifetime. The main limitation of these approaches is that
they imply the generation of transgenic strains, involving a
long and expensive process that requires the use of a large
number of experimentation animals. An alternative
approach is described herein, based on the use of in vivo
gene delivery strategies that potentially overcome previous
limitations, allowing a fast and reliable quantification of* Correspondence: jmpf@uniovi.es
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reproduction in any medium, provided the orthe activity of signaling pathways in a wide variety of
experimental models and physiological situations. Here
we specifically describe a luciferase-based approach to
measure in vivo NF-κB activity in different mice tissues.
NF-κB is involved in the response against a large variety
of external and internal stress signals, having essential roles
in inflammation, immune response, cell proliferation and
protection against apoptosis [12-14]. Consequently with its
key role in cellular stress response, NF-κB aberrant activa-
tion has been linked with several pathophysiological condi-
tions including cancer and accelerated aging [15,16]. In this
regard, it has been described that not only acute NF-κB
activation is related with disease but also subtle changes in
NF-κB activity that persist in time have important biological
consequences, giving rise to chronic inflammatory condi-
tions. The monitoring of these subtle changes in NF-κB
activity has been especially challenging.NF-κB luciferase reporter-based assay
NF-κB activation is most often monitored in cultured cells
using a non-viral vector system that encodes firefly lucifer-
ase reporter gene under the control of a minimal cyto-
megalovirus (CMV) promoter and tandem repeats of the
NF-κB transcriptional response element. The reporter gene
will be only transcribed when NF-κB signaling pathway is
active; otherwise Rel transcription factors are sequestered
in the cytoplasm by an inhibitory complex. Inflammatory
signals trigger NF-κB activation that involves nuclearLtd. This is an Open Access article distributed under the terms of the Creative
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reporter gene will be transcribed, like endogenous NF-κB
targets, proportionally to the magnitude of NF-κB activa-
tion and the time persistence of the induction signal.
Monitoring bioluminescence emission by the tissues upon
luciferin administration allows visualization of NF-κB
activity in vivo.
In vivo gene delivery
Reporter-based strategies in vivo require using highly effi-
cient methods of gene delivery that ensure the transfection
of a high proportion of cells. For liver gene delivery, we
have selected hydrodynamic transfection, a simple and effi-
cient non-viral method that allows transfection of a naked
DNA in a high proportion of the liver hepatocytes [17].
Rapid injection of a high-volume (10%, vol/weight) solution
of the naked plasmid DNA through the tail vein generates
a hydrodynamic pressure that expands liver endothelium
resulting in DNA uptake by the hepatocytes [18,19].
Although the protocol is optimized for mice tissues, the
technique could be modified for other animal models, even
muscles of larger animals [20].
For lung delivery we have used DNA complexed with a
polycation, polyethyleneimine (PEI). DNA-PEI complexes
are efficiently internalized into the cells and the DNA is
subsequently transported into the nucleus [21,22]. Systemic
administration of DNA complexes results in gene delivery
primarily to the lungs, reaching all the anatomical areas of
this organ; this is an important advantage of this method as
compared with others based on instillation, where only the
proximal area is achieved [23].
Methods
Reagents
 Mice. We routinely use 6–20 week-old C57BL/6
mice, but we have also successfully used mice from
other strains (129S1/SvImJ, BALB/c and CD1) as
well as several genetically modified mouse models.
All the animal experiments were performed with the
aproval of the Committee for Animal
Experimentation of the Universidad de Oviedo.
 NF-κB luciferase gene reporter (Qiagen, cat. no.
CCS-013 L).
 In vivo jet-PEI™. Linear 22-kDa polyethylenimine
(see reagent setup) (Polyplus transfection, cat. no.
201-10G).
 Autoclaved Ringer’s solution (123 mM NaCl, 5 mM
KCl and 1.5 mM CaCl2).
 Autoclaved saline. 0.9% (wt/vol) sodium chloride.
 Anesthetic. Isoflurane (Abbott laboratories,
cat. no. 571329.8).
 D-Luciferin firefly luciferase substrate, potassium
salt (Melford laboratories, cat. no. L1350). Escherichia coli lipopolysaccharide (LPS)
(Sigma, L2630).
 Sodium salicylate (Sigma, S3007).
 Endo-Free plasmid maxi kit (Qiagen, cat. no. 12362).
Equipment
 Xenogen or other in vivo luminescence imaging
system (we have used Xenogen IVIS 100 series for
the recording and data analysis).
 Isoflurane vaporizer.
 27-G needle (BD microlance, cat. no. 300635).
 2 mL. syringe (BD discardit, cat. no. 300928).
 45–50°C waterbath and/or heat lamp.
 Shaver to remove mouse hair.
 Scale for weighing mice.
Reagent setup
Preparation of NF-κB luciferase reporter gene
Plasmids are purified by ion-exchange chromatography
using EndoFree plasmid maxi kit following the
manufacturer’s instructions. It is very important that
plasmids used for in vivo gene delivery be free of
endotoxins.
Luciferin stock solution
Prepare a stock solution of luciferin (14.3 mg/mL) by
dissolving 1 g substrate in 70 mL saline solution
(0.9% sodium chloride). Filter the solution through a
0.22 μm sterile filter. Store reconstituted substrate in
aliquots at −80°C. Use 0.2 mL per mice for intraperito-
neal injection.
Preparation of PEI/DNA complexes
For an effective cell delivery of plasmid DNA, the
overall ionic charge of the DNA complexes needs to be
cationic. The amount of nitrogen (N) in the PEI and phos-
phate in the DNA (P) determines the charge of the com-
plexes. In practice, the best transfection results are obtained
with a N/P ratio of 5–10. For this specific
purpose we have successfully used an N/P ratio of 8 and
50 μg of DNA per mice, using a total amount of 8 μL of
jetPEI™ reagent. If using other mouse strains or targeting a
different organ, a dose response should be carried out to
determine the optimal PEI-DNA ratio. Calculate the
amount of in vivo-jetPEI™ in each case as follows:
μL of in vivo jetPEITM ¼ μg of DNA 3ð Þ  N=P ratio
150
Equipment setup
General setup considerations
Prepare all the necessary material, warm up the water
bath, turn on the vaporizer anesthesia machine, and
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mice recovery after the procedure.
Procedure
Mice preparation (Timing 5 min)
1) Check the vaporizer system to ensure adequate
amounts of supply gas (O2) and isoflurane for
duration of the procedure. Make sure system is set
to flow to induction chamber. Turn on supply gas.
Weigh mouse before this point.
2) Turn on flowmeter between 500–1000 mL/min and
place animal in the induction chamber. Turn on
vaporizer to 2-3%. Monitor animals until recumbent.
3) Switch system to flow to nosecone, remove animal
from induction chamber and place in nosecone.
Turn the vaporizer to 1.5-2%.
Preparation of DNA sample and hydrodynamic injection
(Timing 15 min)
4) Calculate the volume required for hydrodynamic
injection based on the weight of the mouse
(10%, vol/weight). For example: a 15 g mouse will
be injected with 1.5 mL of DNA solution.Figure 1 Representative images of the bioluminescence signal registere
transfection (1, 4 and 7 days). Plot represents bioluminescence signal quan
after injection. Mean values are represented as relative values of photon fluxWe normally use a 10 μg/mL DNA solution
although this amount could be varied depending on
the experimental requirements.
5) Dilute DNA in Ringer’s solution and set a syringe
according with the calculated volume.
6) Place the tail of the anesthetized mice in 45–50°C
heated water for 30 s. This will make tail veins more
easily visualized.
7) Mice have two lateral tail veins, both of which are
superficial and could be used for the procedure.
Place the tail with the lateral side up between your
fingers. Inject the needle into the vein 2–3 cm from
the tail tip. You can often see the needle into the
vein.
8) Press with force the plunger of the syringe, trying
to inject the entire volume in less than 10 s. When
finished, remove the needle and apply light
pressure to the injection site until the bleeding
stops.
9) In general, a cohort of several mice could be
injected one after the other, and up to 15–20 mice
could be easily injected in a session.
10) The recovery phase could last up to an hour for full
recovery; we recommend placing the injected mice
under a heat lamp to avoid hypothermia.d in mice at three different time points after hydrodynamic
tification of C57BL/6 complete mice cohort (n=10) during a week
per second and square centimeter, error bars indicate SEM.
Figure 2 Constitutive and LPS-induced measure of liver NF-κB activity. Representative pictures are shown of three C57BL/6 mice before LPS
administration and 24 hours after the injection, half of the cohort also received an injection of sodium salicylate (NaS). Plot represents relative
mean bioluminescence values as photon flux per second and square centimeter, error bars indicate SEM.
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mice (Timing 15 min)
11) Dilute 50 μg of the plasmid in 100 μL of 5% glucose
solution. Vortex gently. Dilute 8 μL of in vivo-jetPEI™
reagent in 100 μL of 5% glucose solution. Combined
both and incubate the 200 μL final volume 15 min at
room temperature (RT). From this point the
complexes are stable for 2 hours at RT. Critical step,
proceed immediately to the next point.
12) Proceed from step 3 and place the tail of the
anesthetized mice under 45–50°C heated water forFigure 3 NF-κB basal activity in mouse lungs. Representative image of
PEI/DNA complexes.30 s. Inject 0.2 mL PEI-complexed DNA into the
lateral vein.
13) Place mice under the heat lamp for recovery.
In vivo bioluminescence imaging (Timing 30 min)
14) Anesthetize mice using isoflurane vaporizer coupled
to the IVIS imaging system. Shave the ventral (for
imaging of liver) or dorsal (for imaging of lungs)
area of the mice. This is especially important for an
adequate imaging of dark-coated mice such as
C57BL/6.three C57BL/6 mice 24 hours after the injection of the
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Imaging should be carried out between 5 and
30 min after luciferin injection. We usually perform
imaging of several mice at the same time.
16) Image the mice according with the equipment
instructions; we have good results with the
Xenogen’s IVIS Living image program selecting a
medium binning and a variable exposure time
depending on signal intensity. Avoid signal
saturation in order to obtain a lineal signal.
Data analysis
17) Change image setting from counts to photons.
Photons are absolute physical units that measure the
light emission from the subject. The radiance unit of
photons/sec/cm2/sr is the number of photons per
second that leave a square centimeter of tissue and
radiate into a solid angle of one steradian (sr).
Measurements in units of radiance automatically
take into account camera settings and allow
comparing data obtained from different animals or
from the same animal in different days.
18) For each mouse draw a measurement region of
interest (ROI), and adjust the threshold value
depending on the intensity of the signal. Obtain a
background-corrected ROI measurement by
subtracting an average background ROI from the
measured ROI by using software computation
options.
19) Critical step. We recommend measuring basal
NF-κB activity starting at 72 hours after the plasmid
injection, the reason is that hydrodynamic delivery
procedure could induce a transient inflammatory
response in the liver that interfere with the
measurements (Figure 1). We have not seen this
effect using PEI/DNA complexes.
Results and discussion
A cohort of C57BL/6 mice was hydrodynamically
transfected with the NF-κB luciferase reporter (Figure 1).
Bioluminescence signals were recorded each day during
a week. According to the data shown, bioluminescence sig-
nal is especially high during the first 48 hours after the in-
jection, rapidly diminishing thereafter and reaching stable
values 72 hours after the injection. This phenomenon is
due to a transient inflammatory response caused by the
hydrodynamic procedure; for this reason, we recommend
measuring NF-κB activity at least 72 hours after injection
in order to prevent potential interference in the signal
recorded.
A potential application of this method to study basal
and acute induced activity of NF-κB in mice livers is
described in the Figure 2. To this end, we first measuredNF-κB basal activity in C57BL/6 mice and then we in-
duced acute inflammation with E. coli lipopolysaccharide
(LPS). Additionally, half of the mice injected with the
LPS received a dose (200 mg/Kg) of sodium salicylate, a
powerful inhibitor of NF-κB signaling. Quantification of
the bioluminescence signals demonstrates the sensitivity
and reproducibility of the method described.
The analysis of constitutive NF-κB activity in the lungs
is showed in Figure 3. PEI/DNA complexes allow an
efficient and highly-specific delivery of the NF-κB
reporter to the lungs.
The method described herein has been successfully
used for studying constitutive and acute-induced NF-κB
signaling in mice tissues [12,24]. The use of this approach
allowed us to demonstrate chronic activation of NF-κB
in two different mouse models of accelerated aging and
to monitor the response in these models to non-steroid
anti-inflammatory drugs [12,16]. These results support
the utility of this approach to study both chronic condi-
tions as well as acute inflammatory responses.
Conclusions
The methodology described herein includes a step-by-
step procedure for liver and lung gene delivery, record-
ing of the bioluminescence signal and data analysis.
Besides, we provide experimental validation of the
protocol, demonstrating the sensitivity and reproducibil-
ity of the method.
The possibility of using viral vectors with different tissue
tropisms for the reporter delivery potentially allows moni-
toring NF-κB in any tissue. Additionally, the same strategy
may be applied for studying different signaling pathways,
replacing the NF-κB response element with other regula-
tory sequences in the luciferase reporter system.
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